Clinical trials
Amyotrophic Lateral Sclerosis trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 9 |
| 2022 | 10 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Terminated | 21 |
| Recruiting | 12 |
| Active, not recruiting | 6 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cytokinetics | 6 |
| Biogen | 4 |
| Eli Lilly and Company | 3 |
| Orion Corporation, Orion Pharma | 3 |
| Amylyx Pharmaceuticals Inc. | 2 |
| Humanitas Mirasole SpA | 2 |
| Knopp Biosciences | 2 |
| Newron Sweden AB | 2 |
| Novartis Pharmaceuticals | 2 |
| Ono Pharmaceutical Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyotrophic Lateral Sclerosis | 65 |
| Motor Neuron Disease | 6 |
| Frontotemporal Dementia | 3 |
| Neurodegenerative Diseases | 2 |
| Alzheimer Disease | 1 |
| Brain Injuries, Traumatic | 1 |
| Brain Stem Infarctions | 1 |
| Fatigue | 1 |
| Locked-In Syndrome | 1 |
| Major Depressive Disorder | 1 |
Trials
Showing 76 to 65 of 65. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.